Decorin Prevents Retinal Pigment Epithelial Barrier Breakdown Under Diabetic Conditions by Suppressing p38 MAPK Activation
The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
Abstract
PURPOSE: The purpose of this study was to determine the effect of decorin on the barrier function of human retinal pigment epithelial (RPE) cells under high-glucose (HG) plus hypoxia conditions. METHODS: Human RPE (ARPE-19) cells were cultured for 18 days in normal glucose (5.5 mM) or HG (25 mM) medium. In addition, to mimic the hypoxic impact which occurs in diabetic retinopathy, cells were treated with 100 μM CoCl2 during the last 2 days of the experiment. Decorin, 100 nM, was applied 1 hour before CoCl2 was added. Retinal pigment epithelial barrier function was evaluated by measuring transepithelial electrical resistance (TER) and apical-basolateral permeability of fluorescein isothiocyanate (FITC)-dextran. The content and distribution of tight junction proteins (claudin-1, occludin, and zonula occludens-1 [ZO-1]) were examined by Western blotting and immunofluorescence. p38 mitogen-activated protein kinase (MAPK) phosphorylation was evaluated by Western blotting, and small interfering RNA transfection to p38 MAPK was also performed in ARPE-19 monolayers. RESULTS: High-glucose plus hypoxia significantly increased FITC-dextran permeability, paralleled by decreased TER. Decorin reversed both of these effects. High-glucose plus hypoxia-induced reduction and disorganization of occludin and ZO-1 were also reversed by decorin. Decorin prevented the activation of p38 MAPK induced by hypoxia. Silence of p38 MAPK by RNA interference also inhibited the breakdown of ARPE-19 cell monolayer induced by HG plus hypoxia. CONCLUSIONS: Retinal pigment epithelial barrier disruption induced by HG plus hypoxia was prevented by decorin through suppression of p38 MAPK activation, which could present a new therapeutic strategy for inhibition of diabetic macular edema.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and for the prevention of macular edema [ 88 , 89 , 90 , 91 ]”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [91]
Citations
Cites
(2007) · Developments in Ophthalmology · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583
Kyriakis, J. M., & Avruch, J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.807 · Cited by 3,382
The Retinal Pigment Epithelium in Visual Function
Strauss, O. (2005) · Physiological Reviews · doi:10.1152/physrev.00021.2004 · Cited by 2,828
Mechanisms and functions of p38 MAPK signalling
Cuadrado, A., & Nebreda, A. R. (2010) · Biochemical Journal · doi:10.1042/bj20100323 · Cited by 1,676
González-Mariscal, L., Betanzos, A., Nava, P., & Jaramillo, B. E. (2003) · Progress in Biophysics and Molecular Biology · doi:10.1016/s0079-6107(02)00037-8 · Cited by 1,160
Klaassen, I., Van Noorden, C. J. F., & Schlingemann, R. O. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.02.001 · Cited by 722
Yu, D.-Y., & Cringle, S. J. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(00)00027-6 · Cited by 653
Proteoglycans in cancer biology, tumour microenvironment and angiogenesis
Iozzo, R. V., & Sanderson, R. D. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01236.x · Cited by 569
Regulation of tight junctions and loss of barrier function in pathophysiology
Harhaj, N. S., & Antonetti, D. A. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2003.08.007 · Cited by 545
Simó, R., Villarroel, M., Corraliza, L., Hernández, C., & Garcia-Ramírez, M. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/190724 · Cited by 463
Cited by
Mechanisms of macular edema: Beyond the surface
Daruich, A., Matet, A., Moulin, A., Kowalczuk, L., Nicolas, M., Sellam, A., Rothschild, P.-R., Omri, S., Gélizé, E., Jonet, L., et al. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.10.006 · Cited by 708
Zhang, C., Xie, H., Yang, Q., Yang, Y., Li, W., Tian, H., Lü, L., Wang, F., Xu, J., Gao, F., et al. (2019) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.13619 · Cited by 68
MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges
Moustardas, P., Aberdam, D., & Lagali, N. (2023) · Cells · doi:10.3390/cells12040617 · Cited by 63
Chiang, Y., Chen, H.-Y., Chang, Y.-J., Shih, Y.-H., Shieh, T., Wang, K.-L., & Hsia, S. (2020) · Antioxidants · doi:10.3390/antiox9121176 · Cited by 60
Damage-Associated Molecular Patterns (DAMPs) in Retinal Disorders
Mahaling, B., Low, S. W. Y., Beck, M., Kumar, D., Ahmed, S., Connor, T. B., Ahmad, B. U., & Chaurasia, S. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052591 · Cited by 59
Metadata
- Authors
- Wang, S., Du, S., Wu, Q., Hu, J., & Li, T.
- Affiliations
- Shanghai Jiao Tong University (CN)
- Corresponding author
- Wu, Qiang
- Venue
- Investigative Opthalmology & Visual Science
- Published
- 2015-05-08
- Volume
- 56
- Issue
- 5
- Pages
- 2971
- ISSN
- 0146-0404 (ISSN-L)
- 1552-5783
- OpenAlex
- W1985449885
- Cited by
- 44
- References
- 54
- Citations by year
- 2026: 2 · 2024: 3 · 2023: 3 · 2022: 7 · 2021: 7 · 2020: 6 · 2019: 5 · 2018: 3 · 2017: 5 · 2016: 3
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Investigative Ophthalmology & Visual Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connexins and lens biology
- Keywords
- decorin, retinal pigment epithelium, blood-retinal barrier, diabetic retinopathy, p38 MAPK, high glucose, hypoxia, tight junction proteins, occludin, ZO-1, claudin-1, transepithelial electrical resistance, ARPE-19 cells, diabetic macular edema, extracellular matrix
- MeSH terms
- Hypoxia, Blood-Retinal Barrier, Cell Membrane Permeability, Cells, Cultured, Cobalt, Dextrans, Diabetic Retinopathy, Fluorescent Antibody Technique, Glucose, Humans, Blotting, Western, Fluorescein-5-isothiocyanate, Electric Impedance, RNA, Small Interfering, p38 Mitogen-Activated Protein Kinases, Retinal Pigment Epithelium, Decorin, Tight Junction Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.